(Q63012083)
Statements
A Single-dose, Two-treatment, Two-sequence, Two-period, Two Way Crossover Bioequivalence Study of Bosiqing Aripiprazole Orally Disintegrating Tablets and ABILIFY Under Fasting/Fed Condition (English)
0 references
26 June 2017
0 references
30 April 2018
0 references
66
0 references
45 year
0 references
65 year
0 references